Clinical Trials Directory

Trials / Sponsors / Golden Biotechnology Corporation

Golden Biotechnology Corporation

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedDouble-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized
Covid-19
Phase 22020-10-15
CompletedEvaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Pati
Leukemia, Myeloid, Acute
Phase 22019-02-20
CompletedA Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
HBV
Phase 22018-08-01
CompletedA Trial of Antroquinonol in Patients With Atopic Dermatitis
Atopic Dermatitis
Phase 22018-07-17
Active Not RecruitingDetermine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Pancreatic Neoplasm
Phase 1 / Phase 22017-12-01
CompletedTrial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Hyperlipidemias
Phase 22016-05-01
CompletedResearch on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
N/A2013-12-01
CompletedEfficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Non-small Cell Lung Cancer Stage IV
Phase 22013-10-01
CompletedDetermine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
Non-small Cell Lung Cancer
Phase 12010-12-01
CompletedA Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects
Healthy
N/A2009-11-01